Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 113,059
  • Shares Outstanding, K 48,110
  • Annual Sales, $ 0 K
  • Annual Income, $ -97,220 K
  • EBIT $ -135 M
  • EBITDA $ -133 M
  • 60-Month Beta -0.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.66

Options Overview Details

View History
  • Implied Volatility 146.60% ( +21.27%)
  • Historical Volatility 524.32%
  • IV Percentile 71%
  • IV Rank 19.80%
  • IV High 480.77% on 11/21/24
  • IV Low 64.13% on 03/27/24
  • Put/Call Vol Ratio 0.60
  • Today's Volume 8,493
  • Volume Avg (30-Day) 13,804
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 293,129
  • Open Int (30-Day) 267,266

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.68
  • Number of Estimates 1
  • High Estimate -0.68
  • Low Estimate -0.68
  • Prior Year -0.50
  • Growth Rate Est. (year over year) -36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +5.38%
on 12/20/24
33.98 -93.08%
on 11/21/24
-23.70 (-90.98%)
since 11/20/24
3-Month
2.23 +5.38%
on 12/20/24
33.98 -93.08%
on 11/21/24
-27.43 (-92.11%)
since 09/20/24
52-Week
2.23 +5.38%
on 12/20/24
42.20 -94.43%
on 08/05/24
-25.41 (-91.53%)
since 12/20/23

Most Recent Stories

More News
News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

SURG : 1.7700 (+2.31%)
PSTX : 9.45 (+0.43%)
KULR : 2.95 (+31.70%)
TOYO : 3.38 (-5.32%)
AVXL : 8.63 (+1.89%)
MAXN : 7.40 (+12.29%)
POET : 4.76 (-1.04%)
SAVA : 2.35 (+2.62%)
News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

SURG : 1.7700 (+2.31%)
KULR : 2.95 (+31.70%)
PSTX : 9.45 (+0.43%)
AVXL : 8.63 (+1.89%)
TOYO : 3.38 (-5.32%)
MAXN : 7.40 (+12.29%)
PTK.VN : 6.840 (-1.30%)
POET : 4.76 (-1.04%)
SAVA : 2.35 (+2.62%)
A Post-Mortem on Cassava Sciences

There are few things in the investment world scarier than owning a biotech that misses the mark. That was the case this morning with once high-flying stock Cassava Sciences (SAVA). This is a stock that...

SAVA : 2.35 (+2.62%)
Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon

D. Boral Capital believes Anavex’s Alzheimer’s treatment is superior to Cassava Sciences' approach.

AVXL : 8.63 (+1.89%)
VTI : 293.28 (+1.14%)
IWM : 221.92 (+0.94%)
SAVA : 2.35 (+2.62%)
Cassava Sciences Stock Craters After Alzheimer’s Disease Trial Flops: Retail’s Devastated

The CEO noted that the findings also impact the company’s second Phase 3 trial, ReFocus-ALZ, which has now been discontinued alongside an Open Label Extension study.

IWO : 290.85 (+1.02%)
VTI : 293.28 (+1.14%)
IWM : 221.92 (+0.94%)
SAVA : 2.35 (+2.62%)
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints

SAVA : 2.35 (+2.62%)
Cassava Sciences to Hold Corporate Update on November 25th

SAVA : 2.35 (+2.62%)
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer to Advance Alzheimer's Treatment Strategy

Cassava Sciences appoints Freda Nassif as Chief Commercial Officer, enhancing its strategy ahead of Phase 3 trial results for Alzheimer's treatment.Quiver AI SummaryCassava Sciences has appointed Freda...

SAVA : 2.35 (+2.62%)
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer

SAVA : 2.35 (+2.62%)
Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...

ANVS : 4.37 (-0.68%)
LLY : 767.76 (+1.35%)
INMB : 4.40 (-0.45%)
XBI : 91.28 (+1.64%)
BIIB : 146.47 (-0.62%)
SAVA : 2.35 (+2.62%)

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 2.61
2nd Resistance Point 2.51
1st Resistance Point 2.43
Last Price 2.35
1st Support Level 2.25
2nd Support Level 2.15
3rd Support Level 2.07

See More

52-Week High 42.20
Fibonacci 61.8% 26.93
Fibonacci 50% 22.22
Fibonacci 38.2% 17.50
Last Price 2.35
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar